Cargando…
A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
Tuberculosis (TB) is one of the world’s leading causes of death due to infection and efforts to control TB would be substantially aided by the availability of an improved TB vaccine. There are currently nine new TB vaccines in clinical development, and the first efficacy trials are due to commence i...
Autores principales: | Fletcher, Helen A., Hawkridge, Tony, McShane, Helen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694314/ https://www.ncbi.nlm.nih.gov/pubmed/19536332 http://dx.doi.org/10.1007/s11673-009-9153-6 |
Ejemplares similares
-
Cholera Toxin Enhances Vaccine-Induced Protection against Mycobacterium Tuberculosis Challenge in Mice
por: Griffiths, Kristin L., et al.
Publicado: (2013) -
Tuberculosis vaccines: beyond bacille Calmette–Guérin
por: McShane, Helen
Publicado: (2011) -
Progress and challenges in TB vaccine development
por: Voss, Gerald, et al.
Publicado: (2018) -
Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
por: Stylianou, Elena, et al.
Publicado: (2019) -
Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
por: McShane, Helen, et al.
Publicado: (2016)